Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor (original) (raw)

References

  1. Early treatment diabetic retinopathy study research group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 98, 766–785 (1991).
  2. Zimmer-Galler, I.E., Bressler, N.M. & Bressler, S.B. Treatment of choroidal neovascularization: updated information from recent macular photocoagulation study group reports. Int. Ophthalmol. Clin. 35, 37–57 (1995).
    CAS PubMed Google Scholar
  3. Pierce, E.A., Foley, E.D. & Smith, L.E. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch. Ophthalmol. 114, 1219–1228 (1996); erratum: 115, 427 (1997).
    Article CAS Google Scholar
  4. Stone, J. et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15, 4738–4747 (1995).
    Article CAS Google Scholar
  5. Stone, J. et al. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 37, 290–299 (1996).
    CAS PubMed Google Scholar
  6. Pierce, E.A., Avery, R.L., Foley, E.D., Aiello, L.P. & Smith, L.E. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA 92, 905–909 (1995).
    Article CAS Google Scholar
  7. Boulton, M., Foreman, D., Williams, G. & McLeod, D. VEGF localisation in diabetic retinopathy. Br. J. Ophthalmol. 82, 561–568 (1998).
    Article CAS Google Scholar
  8. Robinson, G.S. et al. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc. Natl. Acad. Sci. USA 93, 4851–4856 (1996).
    Article CAS Google Scholar
  9. Aiello, L.P. et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. USA 92, 10457–10461 (1995).
    Article CAS Google Scholar
  10. Borgstrom, P., Bourdon, M.A., Hillan, K.J., Sriramarao, P. & Ferrara, N. Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo. Prostate 35, 1–10 (1998).
    Article CAS Google Scholar
  11. Ferrara, N. et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nature Med. 4, 336–340 (1998).
    Article CAS Google Scholar
  12. Smith, L.E. et al. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276, 1706–1709 (1997).
    Article CAS Google Scholar
  13. Sharp, P.S. et al. Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy. Diabetologia 30, 199–207 (1987).
    Article CAS Google Scholar
  14. Merimee, T.J., Fineberg, S.E., McKusick, V.A. & Hall, J. Diabetes mellitus and sexual ateliotic dwarfism: a comparative study. J. Clin. Invest. 49, 1096–1102 (1970).
    Article CAS Google Scholar
  15. Wright, A.D. et al. Serum growth hormone levels and the response of diabetic retinopathy to pituitary ablation. Br. Med. J. 2, 346–348 (1969).
    Article CAS Google Scholar
  16. Sonksen, P.H., Russell-Jones, D. & Jones, R.H. Growth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future? Horm. Res. 40, 68–79 (1993).
    Article CAS Google Scholar
  17. Merimee, T.J., Zapf, J. & Froesch, E.R. Insulin-like growth factors. Studies in diabetics with and without retinopathy. N. Engl. J. Med. 309, 527–530 (1983).
    Article CAS Google Scholar
  18. Amiel, S.A. et al. Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes. Diabetes 33, 1175–1179 (1984).
    Article CAS Google Scholar
  19. Grant, M., Russell, B., Fitzgerald, C. & Merimee, T.J. Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization. Diabetes 35, 416–420 (1986).
    Article CAS Google Scholar
  20. Pfeiffer, A., Spranger, J., Meyer-Schwickerath, R. & Schatz, H. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown. Diabetes 46, S26–30 (1997).
    Article CAS Google Scholar
  21. Meyer-Schwickerath, R. et al. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J. Clin. Invest. 92, 2620–2625 (1993).
    Article CAS Google Scholar
  22. Hyer, S.L., Sharp, P.S., Brooks, R.A., Burrin, J.M. & Kohner, E.M. A two-year follow-up study of serum insulinlike growth factor-I in diabetics with retinopathy. Metabolism 38, 586–589 (1989).
    Article CAS Google Scholar
  23. Dills, D.G., Moss, S.E., Klein, R., Klein, B.E. & Davis, M. Is insulinlike growth factor I associated with diabetic retinopathy? Diabetes 39, 191–195 (1990).
    Article CAS Google Scholar
  24. Dills, D.G., Moss, S.E., Klein, R. & Klein, B.E. Association of elevated IGF-I levels with increased retinopathy in late-onset diabetes. Diabetes 40, 1725–1730 (1991).
    Article CAS Google Scholar
  25. Smith, L.E. et al. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35, 101–111 (1994).
    CAS PubMed Google Scholar
  26. Hayry, P. et al. Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. FASEB J. 9, 1336–1344 (1995).
    Article CAS Google Scholar
  27. Pietrzkowski, Z., Wernicke, D., Porcu, P., Jameson, B.A. & Baserga, R. Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1. Cancer Res. 52, 6447–6451 (1992).
    CAS PubMed Google Scholar
  28. Kroll, J. & Waltenberger, J. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J. Biol. Chem. 272, 32521–32527 (1997).
    Article CAS Google Scholar
  29. Pedram, A., Razandi, M., Hu, R.M. & Levin, E.R. Astrocyte progression from G1 to S phase of the cell cycle depends upon multiple protein interaction. J. Biol. Chem. 273, 13966–13972 (1998).
    Article CAS Google Scholar
  30. Abedi, H. & Zachary, I. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J. Biol.Chem. 272, 15442–15451 (1997).
    Article CAS Google Scholar
  31. Parenti, A. et al. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J. Biol. Chem. 273, 4220–4226 (1998).
    Article CAS Google Scholar
  32. Seger, R. & Krebs, E.G. The MAPK signaling cascade. Faseb. J. 9, 726–735 (1995).
    Article CAS Google Scholar
  33. Pedram, A., Razandi, M., Hu, R.M. & Levin, E.R. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J. Biol. Chem. 272, 17097–17103 (1997).
    Article CAS Google Scholar
  34. Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T. & Saltiel, A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 27489–27494 (1995).
    Article CAS Google Scholar
  35. Baserga, R., Hongo, A., Rubini, M., Prisco, M. & Valentinis, B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta 1332, F105–126 (1997).
    CAS PubMed Google Scholar
  36. King, G.L., Goodman, A.D., Buzney, S., Moses, A. & Kahn, C.R. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J. Clin. Invest. 75, 1028–1036 (1985).
    Article CAS Google Scholar
  37. Grant, M.B., Caballero, S. & Millard, W.J. Inhibition of IGF-I and b-FGF stimulated growth of human retinal endothelial cells by the somatostatin analogue, octreotide: a potential treatment for ocular neovascularization. Regul. Pept. 48, 267–278 (1993).
    Article CAS Google Scholar
  38. Graves, J.D., Campbell, J.S. & Krebs, E.G. Protein serine/threonine kinases of the MAPK cascade. Ann. NY Acad. Sci. 766, 320–343 (1995).
    Article CAS Google Scholar
  39. Klemke, R.L. et al. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137, 481–492 (1997).
    Article CAS Google Scholar
  40. Punglia, R.S. et al. Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. Diabetes 46, 1619–1626 (1997).
    Article CAS Google Scholar
  41. The diabetes control and complications trial. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol. 113, 36–51 (1995).
  42. Dahl-Jorgensen, K., Brinchmann-Hansen, O., Hanssen, K.F., Sandvik, L. & Aagenaes, O. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br. Med. J. (Clin. Res. Ed.) 290, 811–815 (1985).
    Article CAS Google Scholar
  43. Chantelau, E. & Kohner, E.M. Why some cases of retinopathy worsen when diabetic control improves. Br. Med. J. 315, 1105–1106 (1997).
    Article CAS Google Scholar
  44. Hanssen, K.F., Dahl-Jorgensen, K. & Brinchmann-Hansen, O. The influence of strict control on diabetic complications. Acta Endocrinol. Suppl. (Copenh) 272, 57–60 (1985).
    Article CAS Google Scholar
  45. Diabetes control and complications trial research group. Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial. Ophthalmology 102, 647–661 (1995).
  46. Diabetes control and complications trial research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977–986 (1993).
  47. Moskalets, E., Galstyan, G., Starostina, E., Antsiferov, M. & Chantelau, E. Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus. J. Diabetes Complications 8, 45–50 (1994).
    Article CAS Google Scholar
  48. Chantelau, E., Eggert, H., Seppel, T., Schonau, E. & Althaus, C. Elevation of serum IGF-1 precedes proliferative diabetic retinopathy in Mauriac's syndrome. Br. J. Ophthalmol. 81, 169–170 (1997).
    Article CAS Google Scholar
  49. Hammes, H.P., Lin, J., Bretzel, R.G., Brownlee, M. & Breier, G. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes 47, 401–406 (1998).
    Article CAS Google Scholar
  50. Holly, J.M., Amiel, S.A., Sandhu, R.R., Rees, L.H. & Wass, J.A. The role of growth hormone in diabetes mellitus. J. Endocrinol. 118, 353–364 (1988).
    Article CAS Google Scholar
  51. D'Amato, R., Wesolowski, E. & Smith, L.E. Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse. Microvasc. Res. 46, 135–142 (1993).
    Article CAS Google Scholar
  52. Capetandes, A. & Gerritsen, M.E. Simplified methods for consistent and selective culture of bovine retinal endothelial cells and pericytes. Invest. Ophthalmol. Vis. Sci. 31, 1738–1744 (1990).
    CAS PubMed Google Scholar
  53. Bischoff, J., Brasel, C., Kraling, B. & Vranovska, K. E-selectin is upregulated in proliferating endothelial cells in vitro. Microcirculation 4, 279–287 (1997).
    Article CAS Google Scholar
  54. Zhang, B., Tavare, J.M., Ellis, L. & Roth, R.A. The regulatory role of known tyrosine autophosphorylation sites of the insulin receptor kinase domain. An assessment by replacement with neutral and negatively charged amino acids. J. Biol. Chem. 266, 990–996 (1991).
    CAS PubMed Google Scholar

Download references